Abstract
One hundred and fourteen patients with leukemia (66 cytomegalovirus (CMV)-seropositive and 48 CMV-seronegative) were monitored for cytomegaloviremia by early antigen detection or conventional viral culture after autologous stem cell transplantation (ASCT). Twenty-two episodes of viremia were seen at 2–36 weeks (median 11) in 14 seropositive patients. Nineteen resolved without therapy in 11 patients. Three patients with clinical features suggestive of CMV disease were treated with ganciclovir: viremia resolved prior to ganciclovir in one, and with 3 weeks of ganciclovir in the other two. Transient thrombocytopenia (n = 4) and leukopenia (n = 1) were seen in association with five episodes of viremia. The counts recovered in all five patients; with ganciclovir (n = 2) or with spontaneous clearance of viremia (n = 3). One seronegative patient developed viremia which resolved spontaneously in 3 weeks. No symptoms suggestive of CMV disease were seen in any of the other patients. CMV serostatus or development of CMV infection did not affect hematologic recovery. In our experience, cytomegaloviremia is relatively uncommon after autografting for leukemia, and usually does not require treatment. We now do not routinely monitor leukemia patients for CMV infection after autografting, but look for viremia in CMV- seropositive patients with unexplained fever, drop in blood counts, lung infiltrates, or gastrointestinal symptoms.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Singhal, S., Powles, R., Treleaven, J. et al. Cytomegaloviremia after autografting for leukemia: clinical significance and lack of effect on engraftment. Leukemia 11, 835–838 (1997). https://doi.org/10.1038/sj.leu.2400672
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400672
Keywords
This article is cited by
-
Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT
Bone Marrow Transplantation (2008)
-
Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT)
Annals of Hematology (2003)
-
Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL
Bone Marrow Transplantation (2002)
-
Infections during mobilizing chemotherapy and following autologous stem cell transplantation
Bone Marrow Transplantation (2001)
-
Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients
Bone Marrow Transplantation (2001)